118 related articles for article (PubMed ID: 28449193)
1. Impact of metformin on patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
Chang PH; Yeh KY; Wang CH; Chen EY; Yang SW; Chou WC; Hsieh JC
Head Neck; 2017 Aug; 39(8):1573-1577. PubMed ID: 28449193
[TBL] [Abstract][Full Text] [Related]
2. Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
Chang PH; Yeh KY; Wang CH; Chen EY; Yang SW; Huang JS; Chou WC; Hsieh JC
Head Neck; 2017 Oct; 39(10):1990-1996. PubMed ID: 28688124
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiotherapy in elderly patients with advanced head and neck cancer under intensive nutritional support.
Chang PH; Yeh KY; Huang JS; Chen EY; Yang SW; Wang CH
Asia Pac J Clin Oncol; 2015 Sep; 11(3):228-35. PubMed ID: 25535674
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
[TBL] [Abstract][Full Text] [Related]
5. Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease.
Harrington K; Berrier A; Robinson M; Remenar E; Housset M; de Mendoza FH; Fayette J; Mehanna H; El-Hariry I; Compton N; Franklin N; Biswas-Baldwin N; Lau M; Legenne P; Kumar R
Eur J Cancer; 2013 May; 49(7):1609-18. PubMed ID: 23265705
[TBL] [Abstract][Full Text] [Related]
6. A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice.
Pramyothin P; Manyanont S; Trakarnsanga A; Petsuksiri J; Ithimakin S
J Hum Nutr Diet; 2016 Dec; 29(6):768-776. PubMed ID: 27028666
[TBL] [Abstract][Full Text] [Related]
7. Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer.
Lee YJ; Lee CG; Cho BC; Kim GE; Choi HJ; Choi EC; Sohn JH; Kim JH
Head Neck; 2010 Feb; 32(2):235-43. PubMed ID: 19572288
[TBL] [Abstract][Full Text] [Related]
8. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic.
Rütten H; Pop LA; Janssens GO; Takes RP; Knuijt S; Rooijakkers AF; van den Berg M; Merkx MA; van Herpen CM; Kaanders JH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):923-9. PubMed ID: 21095074
[TBL] [Abstract][Full Text] [Related]
10. Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer.
Yoo DS; Kirkpatrick JP; Craciunescu O; Broadwater G; Peterson BL; Carroll MD; Clough R; MacFall JR; Hoang J; Scher RL; Esclamado RM; Dunphy FR; Ready NE; Brizel DM
Clin Cancer Res; 2012 Mar; 18(5):1404-14. PubMed ID: 22253412
[TBL] [Abstract][Full Text] [Related]
11. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
12. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly.
Michal SA; Adelstein DJ; Rybicki LA; Rodriguez CP; Saxton JP; Wood BG; Scharpf J; Ives DI
Head Neck; 2012 Aug; 34(8):1147-52. PubMed ID: 22021098
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
[TBL] [Abstract][Full Text] [Related]
14. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
Koutcher L; Sherman E; Fury M; Wolden S; Zhang Z; Mo Q; Stewart L; Schupak K; Gelblum D; Wong R; Kraus D; Shah J; Zelefsky M; Pfister D; Lee N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):915-22. PubMed ID: 20947269
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nutritional index relevance in chemoradiotherapy for advanced oral cavity, oropharyngeal and hypopharyngeal cancer.
Chang PH; Hsieh JC; Yeh KY; Chen EY; Yang SW; Huang JS; Lai CH; Wu TH; Huang YM; Chang YS; Chou WC; Wang CH
Asia Pac J Clin Nutr; 2018; 27(5):996-1001. PubMed ID: 30272847
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment performance status and nutrition are associated with early mortality of locally advanced head and neck cancer patients undergoing concurrent chemoradiation.
Chang PH; Yeh KY; Huang JS; Lai CH; Wu TH; Lan YJ; Tsai JC; Chen EY; Yang SW; Wang CH
Eur Arch Otorhinolaryngol; 2013 May; 270(6):1909-15. PubMed ID: 23188165
[TBL] [Abstract][Full Text] [Related]
18. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971
[TBL] [Abstract][Full Text] [Related]
20. Sequential TPF chemotherapy followed by concurrent chemoradiotherapy in locally advanced head and neck cancer--a retrospective analysis of toxicity and outcomes.
Sanders IW; Haslett K; Correa P; Paterson C; James A; Rizwanullah M; Grose D
Scott Med J; 2014 Feb; 59(1):50-5. PubMed ID: 24424462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
